(Q44121986)

30 November 2017

title

SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist (English)

1 reference

30 November 2017

0 references

John C Anthes

1

1 reference

30 November 2017

Richard W Chapman

2

1 reference

30 November 2017

Christian Richard

3

1 reference

30 November 2017

Stephen Eckel

4

1 reference

30 November 2017

Michel Corboz

5

1 reference

30 November 2017

John A Hey

6

1 reference

30 November 2017

Xiomara Fernandez

7

1 reference

30 November 2017

Scott Greenfeder

8

1 reference

30 November 2017

Robbie McLeod

9

1 reference

30 November 2017

Susan Sehring

10

1 reference

30 November 2017

Charles Rizzo

11

1 reference

30 November 2017

Yvette Crawley

12

1 reference

30 November 2017

Neng-Yang Shih

13

1 reference

30 November 2017

John Piwinski

14

1 reference

30 November 2017

Greg Reichard

15

1 reference

30 November 2017

Pauline Ting

16

1 reference

30 November 2017

Nick Carruthers

17

1 reference

30 November 2017

Francis M Cuss

18

1 reference

30 November 2017

Motasim Billah

19

1 reference

30 November 2017

William Kreutner

20

1 reference

30 November 2017

Robert W Egan

21

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

European Journal of Pharmacology

30 November 2017

published in

1 reference

30 November 2017

volume

450

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

191-202

1 reference

Antitussive effect of SR 48968, a non-peptide tachykinin NK2 receptor antagonist

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Neuropeptides in the respiratory tract. Part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Combined NK(1)and NK(2)receptor antagonists on the bronchoconstrictor response to NKA in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Tachykinin NK1 receptor-mediated vasorelaxation in human pulmonary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Neurokinin B- and specific tachykinin NK(3) receptor agonists-induced airway hyperresponsiveness in the guinea-pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Tachykinin NK(3) receptor agonists induced microvascular leakage hypersensitivity in the guinea-pig airways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

NK1 and NK2 receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Central modulatory effects of tachykinin peptides on airway tone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Augmentation of neurally evoked cholinergic bronchoconstrictor responses by prejunctional NK2 receptors in the guinea-pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Neutral endopeptidase inhibitors potentiate substance P- and capsaicin-induced cough in awake guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Sch 37224, an experimental antiallergy compound, inhibits the neuropeptide component of hyperventilation- and nicotine-induced bronchoconstriction in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Nonpeptide antagonists of the NK1 tachykinin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Tachykinin receptors: a radioligand binding perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Neurotransmitter functions of mammalian tachykinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

NK1 receptors mediate neurogenic inflammatory increase in blood flow in rat airways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Tachykinins mediate bronchoconstriction elicited by isocapnic hyperpnea in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

NK(2)-receptor mediated contraction in monkey, guinea-pig and human airway smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Neurokinin receptors subserving airways secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Further evidence that tachykinin-induced contraction of human isolated bronchus is mediated only by NK2-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

A method to measure dual NK1/NK2-antagonist activity in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Tachykinin receptor antagonists inhibit hyperpnea-induced bronchoconstriction in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Evidence for substance P as an endogenous substance causing cough in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

Hyperpnea-induced bronchoconstriction is dependent on tachykinin-induced cysteinyl leukotriene synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902124-6

10.1016/S0014-2999(02)02124-6

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference